We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+11.34%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$302M
AUM Growth
+$83.5M
Cap. Flow
+$69.1M
Cap. Flow %
22.88%
Top 10 Hldgs %
15.66%
Holding
829
New
363
Increased
97
Reduced
44
Closed
323

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$10.7M
2
ACN icon
Accenture
ACN
+$6.03M
3
ADBE icon
Adobe
ADBE
+$5.83M
4
LMT icon
Lockheed Martin
LMT
+$2.67M
5
PGR icon
Progressive
PGR
+$2.43M

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Financials 14.46%
3 Consumer Discretionary 12.43%
4 Healthcare 12.24%
5 Industrials 11.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BORR
501
Borr Drilling
BORR
$1.19B
$42.9K 0.01%
+23,465
New +$44.3K
DNUT icon
502
Krispy Kreme
DNUT
$577M
$42.4K 0.01%
+14,563
New +$50.8K
PSEC icon
503
Prospect Capital
PSEC
$1.17B
$41.3K 0.01%
12,974
-22,078
-63% -$76.7K
PLRX icon
504
Pliant Therapeutics
PLRX
$65M
$38.3K 0.01%
33,045
-12,920
-28% -$18.3K
ABUS icon
505
Arbutus Biopharma
ABUS
$915M
$37.5K 0.01%
+12,143
New +$40.3K
WTI icon
506
W&T Offshore
WTI
$518M
$29.4K 0.01%
+17,820
New +$26.3K
AA icon
507
Alcoa
AA
$13.2B
-14,855
Closed -$453K
A icon
508
Agilent Technologies
A
$41.2B
-2,881
Closed -$337K
AAL icon
509
American Airlines Group
AAL
$10.6B
-51,857
Closed -$547K
ABCL icon
510
AbCellera Biologics
ABCL
$2.12B
-28,241
Closed -$63K
ACGL icon
511
Arch Capital
ACGL
$33.6B
-3,508
Closed -$337K
ACRS icon
512
Aclaris Therapeutics
ACRS
$869M
-41,723
Closed -$63.8K
ADNT icon
513
Adient
ADNT
$1.5B
-34,609
Closed -$445K
AEE icon
514
Ameren
AEE
$30.1B
-2,810
Closed -$282K
AFL icon
515
Aflac
AFL
$62.6B
-9,761
Closed -$1.09M
AG icon
516
First Majestic Silver
AG
$9.07B
-28,673
Closed -$192K
AGX icon
517
Argan
AGX
$8.37B
-3,063
Closed -$402K
ALGN icon
518
Align Technology
ALGN
$12.3B
-2,386
Closed -$379K
ALHC icon
519
Alignment Healthcare
ALHC
$2.98B
-61,949
Closed -$1.15M
ALK icon
520
Alaska Air
ALK
$5.58B
-4,915
Closed -$242K
OSG
521
Octave Specialty Group
OSG
$222M
-42,123
Closed -$369K
AME icon
522
Ametek
AME
$58.2B
-1,230
Closed -$212K
AMRX icon
523
Amneal Pharmaceuticals
AMRX
$5.79B
-20,725
Closed -$174K
AMZN icon
524
Amazon
AMZN
$2.96T
-8,942
Closed -$1.7M
ANAB icon
525
AnaptysBio
ANAB
$1.68B
-14,473
Closed -$269K

Similar funds

Oxford Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Oxford Asset Management held 829 positions worth $302M, up 38% from $219M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oxford Asset Management deployed $69.1M of net new capital in Q2 2025, opening 363 new positions and adding to 97 existing holdings. Its largest new stake was Accenture: 19,786 shares worth $5.91M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Marvell Technology, an estimated $1.18M trimmed.

  • Oxford Asset Management's largest Q2 2025 buy was Accenture: 19,786 shares worth $5.91M.
  • Oxford Asset Management added most to State Street SPDR S&P Biotech ETF in Q2 2025, an estimated $10.7M increase.
  • Oxford Asset Management's biggest Q2 2025 reduction was Marvell Technology, cutting an estimated $1.18M.
  • Oxford Asset Management fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $2.64M.
  • Oxford Asset Management's ten largest holdings make up 16% of its $302M portfolio in Q2 2025.
  • Oxford Asset Management opened 363 new positions and closed 323 in Q2 2025.
  • Oxford Asset Management's portfolio value rose 38% quarter-over-quarter to $302M.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.